These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 6190548

  • 1. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A, Cummings G, Al-Sarraf M.
    Cancer; 1983 Aug 01; 52(3):399-403. PubMed ID: 6190548
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O.
    Cancer; 1987 Sep 15; 60(6):1173-7. PubMed ID: 2441836
    [Abstract] [Full Text] [Related]

  • 3. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH, Baker SR, Liepman MK, Ensminger WD.
    Med Pediatr Oncol; 1983 Sep 15; 11(1):12-9. PubMed ID: 6188032
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of 2 chemotherapy induction protocols. Cisplatinum-methotrexate-bleomycin and oncovin-methotrexate-bleomycin].
    Laccourreye H, Beutter P, Brasnu D, Lacau-Saint-Guily J, Bassot V, Garabedian N, Jacquillat C.
    Ann Otolaryngol Chir Cervicofac; 1983 Sep 15; 100(4):269-74. PubMed ID: 6192747
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer: phase II.
    Amer MH, Izbicki RM, Vaitkevicius VK, Al-Sarraf M.
    Cancer; 1980 Jan 15; 45(2):217-23. PubMed ID: 6153149
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
    Clavel M, Vermorken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornagel JH, Tueni EA, Verweij J, Wildiers J, Clerico M.
    Ann Oncol; 1994 Jul 15; 5(6):521-6. PubMed ID: 7522527
    [Abstract] [Full Text] [Related]

  • 7. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
    Vogl SE, Schoenfeld DA, Kaplan BH, Lerner HJ, Engstrom PF, Horton J.
    Cancer; 1985 Aug 01; 56(3):432-42. PubMed ID: 2408735
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R, Paladine W, Ruckdeschel JC, Goldstein JC, Olson JE, Jaski JW, Silvers SA, Hillinger S, Horton J.
    Cancer Treat Rep; 1979 Mar 01; 63(3):489-91. PubMed ID: 85494
    [No Abstract] [Full Text] [Related]

  • 9. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW, Halpin JJ, Smith RE, Batley F, Schuller DE.
    Cancer Treat Rep; 1979 Mar 01; 63(11-12):1735-8. PubMed ID: 93508
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec 01; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 12. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC, Fabian RL.
    Laryngoscope; 1992 Aug 01; 102(8):901-6. PubMed ID: 1379664
    [Abstract] [Full Text] [Related]

  • 13. [Randomized trial of vincristin-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer (author's transl)].
    Cappelaere P, Chauvergne J, Klein T, Gary-Bobo J, Guerrin J, Meeus L.
    Bull Cancer; 1981 Aug 01; 68(5):422-7. PubMed ID: 6174165
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F, Pinnarò P, Carlini P, Ruggeri EM, Ambesi Impiombato F, Del Vecchio MR, Giannarelli D, Perrino A.
    Cancer; 1988 Jul 15; 62(2):251-61. PubMed ID: 2454721
    [Abstract] [Full Text] [Related]

  • 15. Combination of cis-platinum, oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck.
    Peppard SB, Al-Sarraf M, Powers WE, Loh JK, Weaver AW.
    Laryngoscope; 1980 Aug 15; 90(8 Pt 1):1273-80. PubMed ID: 6157067
    [Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL, Stewart J, Fox RM, Tattersall MH.
    Cancer Treat Rep; 1979 Aug 15; 63(11-12):1997-9. PubMed ID: 93514
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK.
    J Clin Oncol; 1992 Aug 15; 10(8):1245-51. PubMed ID: 1634913
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R, Honegger HP, Grossenbacher R, Mermillod B, Kaplan E, Gervasi A, Wolfensberger M, Lehmann W, Cavalli F.
    Eur J Cancer Clin Oncol; 1987 Jan 15; 23(1):47-53. PubMed ID: 2439344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.